Li Jingyang increased his holding of Huakang Biomed (08622) by approximately 139 million shares, with a price of 0.1175 Hong Kong dollars per share.
On January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, with a price of 0.1175 Hong Kong dollars per share, for a total amount of 16.29396 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on January 10th, Li Jingyang increased his holdings of Huakang Biomedical (08622) by 138.672 million shares, at a price of HK$0.1175 per share, for a total amount of HK$16.29396 million. After the increase, the latest number of shares held is 138.672 million, with a latest shareholding percentage of 27.71%.
Related Articles
The day before the results, Mizuho Securities is bullish on Micron Technology (MU.US): raising the target price to $182, optimistic about the prospects of HBM and memory.
On-site investigation of Contemporary Amperex Technology (300750.SZ) by Morgan Stanley: the conclusion is that its core competitiveness is too strong and next year's production capacity will reach 1TWh with great potential in energy storage.
HK Stock Market Move | NIO-SW(09866) rises more than 8%, reaching a new high in nearly a year. The all-new ES8 will officially go on sale this Saturday.
The day before the results, Mizuho Securities is bullish on Micron Technology (MU.US): raising the target price to $182, optimistic about the prospects of HBM and memory.
On-site investigation of Contemporary Amperex Technology (300750.SZ) by Morgan Stanley: the conclusion is that its core competitiveness is too strong and next year's production capacity will reach 1TWh with great potential in energy storage.
HK Stock Market Move | NIO-SW(09866) rises more than 8%, reaching a new high in nearly a year. The all-new ES8 will officially go on sale this Saturday.
